Advanced Biomed Inc. (ADVB)
NASDAQ: ADVB · Real-Time Price · USD
1.650
-0.100 (-5.71%)
At close: Nov 20, 2026, 4:00 PM EST
1.660
+0.010 (0.61%)
After-hours: Nov 20, 2026, 5:57 PM EST
Advanced Biomed Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 0.21 | 0.39 | 0.03 | 2.61 | 2.62 | 4.78 |
Cash & Short-Term Investments | 0.21 | 0.39 | 0.03 | 2.61 | 2.62 | 4.78 |
Cash Growth | -91.94% | 1138.11% | -98.81% | -0.55% | -45.18% | 7156.86% |
Other Receivables | - | 13.36 | - | 0.21 | 0.15 | 0.16 |
Receivables | - | 13.36 | - | 0.21 | 0.15 | 0.16 |
Prepaid Expenses | 12.65 | 0 | 1.84 | 0.24 | 0.01 | 0.06 |
Other Current Assets | - | - | 20.51 | - | - | - |
Total Current Assets | 12.87 | 13.75 | 22.38 | 3.05 | 2.79 | 5.01 |
Property, Plant & Equipment | 0.03 | - | - | 0.65 | 0.95 | 1.23 |
Other Intangible Assets | - | - | - | 0.12 | 0.25 | 0.41 |
Long-Term Deferred Tax Assets | 0 | 0 | - | - | - | - |
Long-Term Deferred Charges | - | - | - | 0.64 | 0.55 | - |
Other Long-Term Assets | - | - | 0.48 | - | 0.06 | 0.07 |
Total Assets | 12.9 | 13.75 | 22.86 | 4.46 | 4.6 | 6.71 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 1.58 | - | - | 0.62 | 0.63 | 0.76 |
Accrued Expenses | - | 0.37 | 0.53 | 0.08 | 0.09 | 0.1 |
Short-Term Debt | - | 1.08 | - | 0.78 | - | - |
Current Portion of Leases | 0.01 | - | - | 0.06 | 0.22 | 0.24 |
Other Current Liabilities | - | 0.02 | 18.71 | 1.18 | 2.34 | 1.89 |
Total Current Liabilities | 1.59 | 1.47 | 19.24 | 2.73 | 3.28 | 2.99 |
Long-Term Leases | 0.02 | - | - | 0.06 | 0.02 | 0.23 |
Other Long-Term Liabilities | - | - | 0.15 | - | - | - |
Total Liabilities | 1.61 | 1.47 | 19.38 | 2.8 | 3.29 | 3.22 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 0 | 0 | 0 | 0.02 | 0.02 | 0.1 |
Additional Paid-In Capital | 23.86 | 23.86 | 21.37 | 16.49 | 13.67 | 12.58 |
Retained Earnings | -13.55 | -12.56 | -19.23 | -15.97 | -13.19 | -9.46 |
Comprehensive Income & Other | 0.97 | 0.97 | 1.34 | 1.12 | 0.8 | 0.27 |
Shareholders' Equity | 11.29 | 12.28 | 3.48 | 1.66 | 1.31 | 3.49 |
Total Liabilities & Equity | 12.9 | 13.75 | 22.86 | 4.46 | 4.6 | 6.71 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 0.03 | 1.08 | - | 0.91 | 0.24 | 0.47 |
Net Cash (Debt) | 0.18 | -0.69 | 0.03 | 1.7 | 2.39 | 4.31 |
Net Cash Growth | -81.09% | - | -98.17% | -28.92% | -44.68% | 7225.84% |
Net Cash Per Share | 0.13 | -0.55 | 0.03 | 1.70 | 2.39 | 6.08 |
Filing Date Shares Outstanding | 1.65 | 1.65 | 1.08 | 1 | 1 | 1 |
Total Common Shares Outstanding | 1.65 | 1.65 | 1.08 | 1 | 1 | 0.99 |
Working Capital | 11.28 | 12.28 | 3.14 | 0.32 | -0.49 | 2.02 |
Book Value Per Share | 6.83 | 7.43 | 3.21 | 1.66 | 1.31 | 3.53 |
Tangible Book Value | 11.29 | 12.28 | 3.48 | 1.54 | 1.06 | 3.08 |
Tangible Book Value Per Share | 6.83 | 7.43 | 3.21 | 1.54 | 1.06 | 3.11 |
Machinery | - | - | - | 1.55 | 1.51 | 1.38 |
Leasehold Improvements | - | - | - | 0.2 | 0.2 | 0.21 |